Emblem Announces Exclusive Agreement with Canntab Therapeutics for Cannabinoid Based Oral Sustained Release Formulation

Emblem Announces Exclusive Agreement with Canntab Therapeutics for Cannabinoid Based Oral Sustained Release Formulation    Emblem Corp. (TSXV:EMC) (EMC.WT) (“Emblem” or the “Company”) announced today that it has entered into a Collaboration and Licensing Agreement (the “Agreement”) with Canntab Therapeutics Limited (“Canntab”) of Toronto. Canntab has developed a patent-pending oral sustained release formulation for cannabinoids
Complete Reading

Japan 225 stock index posts bullish trend after a failure swing The Japan 225 stock index failed to post a lower low on September 11 and confirmed a failure swing on September 12 when it picked above 19737, which extended to an uptrend, sending the index to a multi-month high of 20624 on October 3. Bias in
Complete Reading

(European Session) – Dollar retreats as investors take profits; euro rebounds Dollar retreats The dollar pared earlier gains during the European trading hours as investors were engaging in profit-taking, while the euro managed to rebound despite political uncertainty remaining in the background. The dollar index retreated from the 1 ½-month high of 93.92, falling to 93.45 before
Complete Reading

Euro Stoxx 50 forecast analysis Euro Stoxx 50 increased 1 points or 0.03% to 3603 on Tuesday October 3 from 3603 in the previous trading session. Historically, the EURO STOXX 50 Stock Market Index reached an all time high of 4557.57 in July of 2007 and a record low of 1809.98 in March of 2009.
Complete Reading

FTSE 100 forecast analysis FTSE 100 increased 26 points or 0.34% to 7463 on Tuesday October 3 from 7439 in the previous trading session. Historically, the UK FTSE 100 Stock Market Index reached an all time high of 7547.63 in May of 2017 and a record low of 427.50 in February of 1978. FTSE 100
Complete Reading

Create Account



Log In Your Account